Qualitative and quantitative procedures for health risk assessment

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 428, Issue 1-2, 1999, Pages 237-254

  Lohman, Paul H M ^a  

^a Dept Radiat Genet Chem M   (Netherlands)

Author keywords

Cancer risk; Genotoxic potency; Hazard assessment; Risk assessment; Structure activity relationship

Indexed keywords

ACRYLAMIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ASBESTOS; AZATHIOPRINE; CARCINOGEN; CHLOROFORM; CHLORPHENOTANE; CYCLOSPORIN A; DELTAMETHRIN; DIAZEPAM; ENVIRONMENTAL MUTAGEN; HALOTHANE; HEAVY METAL; INDUSTRIAL TOXIC SUBSTANCE; ISONIAZID; MESTRANOL; MUTAGENIC AGENT; NITROFURAL; ORGANIC SOLVENT; PESTICIDE; PHENOL DERIVATIVE; POLYCHLORINATED BIPHENYL; PURINE DERIVATIVE; SULFUR DIOXIDE; THEOPHYLLINE; TOLUENE; TRICHLOROETHYLENE; UNINDEXED DRUG; XYLENE;

CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; CONFERENCE PAPER; DNA STRAND; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HEALTH HAZARD; HUMAN; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION;

AGING; CARCINOGENS, ENVIRONMENTAL; DNA; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MUTAGENICITY TESTS; MUTAGENS; NEOPLASMS; NETHERLANDS; POPULATION DYNAMICS; RISK ASSESSMENT;

RODENTIA;

EID: 0032774819     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00051-4     Document Type: Conference Paper

References (25)

1. D. Brusick, Unified scoring system and activity definitions for results from in vitro and submammalian mutagenesis test batteries. in: C.R. Richmond, P.J. Walsh, E. Copenhaver (Eds.), Health Risk Analysis, Proc. 3rd Life Sciences Symp., Gatlinburg, TN, October 27-30, 1980, Franklin Institute, Philadelphia, 1981, pp. 273-286.
2. Brusick D.J., Ashby J., de Serres F.J., Lohman P.H.M., Matsushima T., Matter B.E., Mendelsohn M.L., Moore D.H. II, Nesnow S., Waters M.D. A method for combining and comparing short-term genotoxicity test data: preface. Mutation Res. 266:1992;1-6.
3. Lohman P.H.M., Mendelsohn M.L., Moore D.H. II, Waters M.D., Brusick D.J., Ashby J., Lohman W.J.A. A method for comparing and combining short-term genotoxicity test data: the basic system. Mutation Res. 266:1992;7-25.
4. Moore D.H. II, Mendelsohn M.L., Lohman P.H.M. A method for comparing, combining and interpreting short-term genotoxicity test data: the optimal use of dose information. Mutation Res. 266:1991;27-42.
5. Mendelsohn M.L., Moore D.H. II, Lohman P.H.M. A method for comparing, combining and interpreting short-term genotoxicity test data: results and interpretation. Mutation Res. 266:1991;43-60.
6. Ashby J. Two million rodent carcinogens? The role of SAR and QSAR in their detection. Mutation Res. 305:1994;3-12.
7. Vogel E.W., Barbin A., Nivard M.J.M., Stack H.F., Waters M.D., Lohman P.H.M. Heritable and cancer risk of exposure to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents. Mutation Res. 400:1998;509-540.
8. Gold L.A., Ames B.N. Too many rodent carcinogens? Science. 249:1990;970-971.
9. Gold L.S., Manley N.B., Slone T.H., Garfinkel G.B., Ames B.N., Rohrbach L., Stern B.R., Chow K. Sixth plot of the carcinogenic potency database; results of animal bioassays published in the general literature 1989 to 1990 and by the National Toxicology Program through 1990 to 1993. Environ. Health Perspect. 103:1995;3-122. Suppl. 8.
10. Jackson M.A., Stack H.F., Waters M.D. Activity profiles of carcinogenicity data: application in hazard identification and risk assessment. Mutation Res. 394:1997;113-124.
11. Sugimura T. Cancer prevention: past, present, future. Mutation Res. 402:1998;7-14.
12. Lohman P.H.M., Sankaranarayanan K., Ashby J. Choosing the limits to life. Nature. 357:1992;185-186.
13. M.D. Waters, The GENE-TOX program, in: A.W. Hsie, J.P. O'Neill, V.K. McElheny (Eds.), Banbury Report 2, Cold Spring Harbor, Cold Spring Harbor Laboratory, 1979, pp. 449-467.
14. Waters M.D., Auletta A. The GENE-TOX program: genetic activity evaluation. J. Chem. Inf. Comput. Sci. 21:1981;35-38.
15. Waters M.D., Stack H.F., Brady A.L., Lohman P.H.M., Haroun L., Vainio H. Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds. Mutation Res. 205:1988;295-312.
16. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Suppl. 6, Genetic and related effects: An updating of selected IARC Monographs from Vols. 1 to 42, International Agency for Research on Cancer, Lyon, France, 1987.
17. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Suppl. 7, Overall Evaluation of Carcinogenicity: An updating of selected IARC Monographs from Vols. 1 to 42, International Agency for Research on Cancer, Lyon, France, 1987.
18. van Houwelingen J.C. Statistics of survival. Dutch Journal of Medicine. 135:1991;1735-1744. publication in the Dutch language, Dutch title: De statistiek van overlevingscurven.
19. Fries J.F. Aging, illness, and health policy: implications of the compression of morbidity. Pers. Biol. Med. 31:1988;407-428.
20. Fries J.F., Green L.W., Levine S. Health promotion and the compression of morbidity. Lancet. I:1989;481-483.
21. Institute Statistics Netherlands, Causes of Death in the Dutch Population 1993 - Section A4, SDU publisher, The Hague, The Netherlands, 1993, pp. 1-180 (publication in the Dutch language).
22. J.A. Miller, E.C. Miller, Ultimate chemical carcinogens as reactive mutagenic electrophiles, in: H.H. Hiatt, J.D. Watson, J.A. Winsten (Eds.), Origins of human cancer, book B: Mechanisms of carcinogenesis, Cold Spring Harbor Conferences on cell proliferation, Vol. 4, 1977, pp. 605-627.
23. Tennant R.W., Margolin B.H., Shelby D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
24. Nesnow S. A multi-factor carcinogen potency ranking scale for comparing the activity of chemicals. Mutation Res. 239:1990;83-115.
25. Vogel E.W., Nivard M.J.M., Ballering L.A.B., Bartsch H., Barbin A., Nair J., Comendador M.A., Sierra L.M., Aguirrezabalaga I., Tosal L., Ehrenberg L., Fuchs R.P.P., Janel-Bintz R., Maenhaut-Michel G., Montesano R., Hall J., Kang H., Miele M., Thomale J., Bender K., Engelbergs J., Rajewsky M. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation. Mutation Res. 353:1996;177-218.